Steroid-Responsive Myelitis in Dogs - Comparison with Steroid-Responsive Meningitis-Arteritis

Authors

  • Yoonhoi Koo Laboratroy of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University https://orcid.org/0000-0002-3810-4193
  • Taesik Yun Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of South Korea. https://orcid.org/0000-0003-1372-4430
  • Yeon Chae Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of South Korea. https://orcid.org/0000-0002-9816-6900
  • Dohee Lee Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of South Korea.
  • Hakhyun kim Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of South Korea. https://orcid.org/0000-0002-8882-2329
  • Mhan-Pyo Yang Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of South Korea. https://orcid.org/0000-0002-8043-0152
  • Byeong-Teck Kang Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of South Korea. https://orcid.org/0000-0002-4471-4342

DOI:

https://doi.org/10.22456/1679-9216.126923

Abstract

Background: Myelitis is the inflammation of the spinal cord parenchyma alone, whereas meningitis is the inflammation of the meninges. Steroid-responsive meningitis-arteritis (SRMA) is a meningomyelitis in which the major lesions involve the meninges, not the spinal cord parenchyma, and respond well to glucocorticoid treatment. However, myelitis in dogs has rarely been reported, and myelitis with a good response to glucocorticoid treatment without relapse has not been reported. This report describes 5 cases of steroid-responsive myelitis (SRM) in dogs.
Cases: Case 1. A 8-year-old intact female Cocker Spaniel presented with progressive nonambulatory paraplegia. Whole spinal parenchymal lesions were identified using magnetic resonance imaging (MRI) scan. Mononuclear pleocytosis with increased total protein levels was the only abnormal finding on cerebrospinal fluid (CSF) analysis. Prednisolone (PDS) was administered followed by dose tapering according to therapeutic response. Cyclosporine was administered until the termination of PDS. Since then, no recurrence of neurological symptoms has been observed. Follow-up MRI and CSF analysis revealed resolution of previously observed abnormal findings. Case 2. A 2-year-old intact female Maltese presented with non-progressive paraparesis. A spinal parenchymal lesion in the lumbosacral region was observed on MRI. PDS was administered and slowly tapered at approximately 3-week intervals. No recurrence of neurological symptoms was observed after the treatment. Case 3. A 6-year-old intact female Miniature Pinscher presented with neck pain, along with leukocytosis and neutrophilia. Cervical spinal parenchyma lesions were revealed through MRI. Increased total protein concentration with mixed cell pleocytosis was observed on CSF analysis. Immunomodulatory therapy, similar to that in case 2, was initiated. A second MRI and CSF analysis revealed an improvement in the previously observed abnormalities. Case 4. A 2-year-old, intact female Toy Poodle presented with acute paraplegia and back pain. Lesions were observed in the spinal parenchyma at the T12-L3 levels on MRI. The treatment was conducted as in case 2. During treatment, neurological symptoms, including paraplegia and back pain, were not observed. Follow-up MRI revealed improvement in the spinal lesion. Case 5. A 6-month-old, castrated male Standard Poodle presented with progressive paraparesis. On MRI, lesions were observed in the T11-T13 regions. Immunomodulation therapy, similar to that in case 2, was initiated. No recurrence of neurological symptoms was observed after treatment initiation.

Discussion: SRM is similar to SRMA in terms of good steroid-responsiveness and noninfectious inflammation etiology; however, it does not exactly satisfy the diagnostic criteria for SRMA, nor does it progress similarly. The characteristics of SRM that do not satisfy the diagnostic criteria of SRMA include the absence of fever, C-reactive protein elevation, hyperglobulinemia, and relapse, and the presence of spinal parenchymal lesions without parenchymal or meningeal enhancement on MRI. It is also a seemingly different from spinal cord-only meningoencephalomyelitis of unknown origin due to its better treatment response and prognosis. However, the dogs in the present report with SRM satisfied the diagnostic criteria for transverse myelitis in human patients. Therefore, SRM, including good steroid responsiveness and good prognosis without relapse, may represent a novel type of meningomyelitis.


Keywords: canine, inflammatory spinal cord disease, myelitis, spinal cord, steroid.

Downloads

Download data is not yet available.

References

Avila M., Bansal A., Culberson J. & Peiris A.N. 2018. The role of sex hormones in multiple sclerosis. European Neurology. 80(1-2): 93-99.

Awad A. & Stüve O. 2011. Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices. Current Neuropharmacology. 9(3): 417-428.

Besteiro B. & Guimarães J. 2017. Review of the etiological causes and diagnosis of myelitis and its medical orientation protocol. Journal of Neurology and Neurophysiology. 8: 415. DOI: 10.4172/2155-9562.1000415

Biedermann E., Tipold A. & Flegel T. 2016. Relapses in dogs with steroid-responsive meningitis-arteritis. The Journal of Small Animal Practice. 57(2): 91-95.

Cizinauskas S., Jaggy A. & Tipold A. 2000. Long-term treatment of dogs with steroid-responsive meningitis-arteritis: clinical, laboratory and therapeutic results. The Journal of Small Animal Practice. 41(7): 295-301.

Cornelis I., Volk H.A., Van Ham L. & De Decker S. 2017. Clinical presentation, diagnostic findings and outcome in dogs diagnosed with presumptive spinal-only meningoencephalomyelitis of unknown origin. The Journal of Small Animal Practice. 58(3): 174-182.

Defresne P., Hollenberg H., Husson B., Tabarki B., Landrieu P., Huault G., Tardieu M. & Sébire G. 2003. Acute transverse myelitis in children: clinical course and prognostic factors. Journal of Child Neurology. 18(6): 401-406.

Dewey C.W. 2016. Encephalopathies: Disorders of the Brain. In: Practical Guide to Canine and Feline Neurology. Hoboken: John Wiley & Sons, pp.141-236.

Jung D.I., Kang B.T., Park C., Yoo J.H., Gu S.H., Jeon H.W., Kim J.W., Heo R.Y., Sung H.J., Eom K.D., Lee

J.H., Woo E.J. & Park H.M. 2007. A comparison of combination therapy (cyclosporine plus prednisolone) with sole prednisolone therapy in 7 dogs with necrotizing meningoencephalitis. The Journal of Veterinary Medical Science. 69(12): 1303-1306.

Jung D.I., Kim J.W. & Park H.M. 2012. Long-term immunosuppressive therapy with cyclosporine plus prednisolone for necrotizing meningoencephalitis in a Pekingese dog. The Journal of Veterinary Medical Science. 74(6): 765-769.

Lowrie M., Smith P.M. & Garosi L. 2013. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol. The Veterinary Record. 172(20): 527. DOI: 10.1136/vr.101431

Maiolini A., Carlson R. & Tipold A. 2012. Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis. Journal of Neuroinflammation. 9: 226. DOI: 10.1186/1742-2094-9-226

Rose J.H., Kwiatkowska M., Henderson E.R., Granger N., Murray J.K. & Harcourt-Brown T.R. 2014. The impact of demographic, social, and environmental factors on the development of steroid-responsive meningitis-arteritis (SRMA) in the United Kingdom. Journal of Veterinary Internal Medicine. 28(4): 1199-1202.

Schwartz M., Puff C., Stein V.M., Baumgärtner W. & Tipold A. 2011. Pathogenetic factors for excessive IgA production: Th2-dominated immune response in canine steroid-responsive meningitis-arteritis. Veterinary Journal. 187(2): 260-266.

Tipold A. & Schatzberg S.J. 2010. An update on steroid responsive meningitis-arteritis. The Journal of Small Animal Practice. 51(3): 150-154.

Tipold A. & Stein V.M. 2010. Inflammatory diseases of the spine in small animals. The Veterinary Clinics of North America Small Animal practice. 40(5): 871-879.

Tipold A., Vandevelde M. & Zurbriggen A. 1995. Neuroimmunological studies in steroid-responsive meningitisarteritis in dogs. Research in Veterinary science. 58(2): 103-108.

Wingerchuk D.M. 2009. Neuromyelitis optica: effect of gender. Journal of the neurological Sciences. 286(1-2): 18-23.

West T.W., Hess C. & Cree B.A. 2012. Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies. Seminars in Neurology. 32(2): 97-113.

Yiu E.M., Kornberg A.J., Ryan M.M., Coleman L.T. & Mackay M.T. 2009. Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities? Journal of Child Neurology. 24(3): 287-296.

Additional Files

Published

2023-02-28

How to Cite

Koo, Y., Yun, T., Chae, Y., Lee, D., kim, H., Yang, M.-P., & Kang, B.-T. (2023). Steroid-Responsive Myelitis in Dogs - Comparison with Steroid-Responsive Meningitis-Arteritis. Acta Scientiae Veterinariae, 51. https://doi.org/10.22456/1679-9216.126923

Most read articles by the same author(s)